Increasing the Effectiveness of the Diabetes Prevention Program

March 20, 2018 updated by: Barbel Knauper, McGill University

Increasing the Effectiveness of the Diabetes Prevention Program Through If-then Plans and Mental Practice: A Parallel Randomized Trial

The Diabetes Prevention Program (DPP) is highly effective in promoting weight loss in overweight and obese individuals (e.g., 7% average loss of body weight), and thereby reducing the risk of developing weight-related health consequences. One-on-one DPP sessions, however, are costly and the group-delivered DPP version, the Group Lifestyle Balance program (GLB), is less effective (4% average loss of body weight). The aim of this two-arm parallel randomized controlled trial is to increase the effectiveness of the GLB by integrating habit formation techniques, namely if-then plans and their mental practice, into the program. The study will provide evidence-based data on the effectiveness of an enhanced GLB intervention in promoting weight loss and in reducing weight-related risk factors for chronic health problems.

Study Overview

Status

Completed

Conditions

Detailed Description

Please see brief summary.

Study Type

Interventional

Enrollment (Actual)

172

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H3A 1B1
        • McGill University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • men and women
  • ages of 18 and 75
  • overweight or obese (BMI 28-45 kg/m2)
  • sedentary (< 200 min/week of moderate or vigorous exercise)
  • waist circumference of >= 88cm for women and >= 102cm for men

Exclusion Criteria:

  • diabetes (hemoglobin A1c < 7.0%).
  • taking the medication metformin (used for treating pre-diabetes or diabetes)
  • having been pregnant in the past 6 months or planning on becoming pregnant in the next 2 years
  • currently undergoing treatment for cancer
  • using medication that affects body weight (e.g., loop diuretics)
  • being unable to participate in regular moderate physical activity
  • having severe uncontrolled hypertension (> 190/100mm Hg)
  • being unable to communicate in English or French
  • being diagnosed with bulimia nervosa, currently active major depression, or other severe psychiatric disease (including dementia);
  • suffering from a heart attack, stroke, or heart failure within the past 6 months
  • experiencing excessive weight loss (more than 10 pounds or 4.54 kilograms) in the past 3 months
  • currently participating in another weight loss program
  • having had bariatric surgery in the past 2 years or plans on getting it in the near future
  • planning on moving away from Montreal within the next year
  • having another member of one's household enrolled in the program.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Enriched GLB
This arm aims to increase the effectiveness of the Group Lifestyle Balance (GLB) program by integrating habit formation techniques, namely if-then plans and their mental practice, into the program.
Habit formation techniques, namely if-then plans and their mental practice are being added to the standard Group Lifestyle Balance program.
Other Names:
  • mental imagery
  • implementation intentions
  • weight loss program
  • Diabetes Prevention Program
Active Comparator: Standard GLB
This arm is the standard Group Lifestyle Balance (GLB) program, which is the group version of the Diabetes Prevention Program developed by the NIH.
This arm is the standard Group Lifestyle Balance program
Other Names:
  • weight loss program
  • Diabetes Prevention Program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent body weight loss
Time Frame: 3 months after beginning of the intervention
The primary outcome will be percent body weight loss from baseline to 3 months after the beginning of the intervention. Weight in kg.
3 months after beginning of the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent body weight loss
Time Frame: 12 months
Percent body weight loss 12 months after the beginning of the intervention. Weight in kg.
12 months
Percent body weight loss
Time Frame: 24 months
Percent body weight loss 24 months after the beginning of the intervention. Weight in kg.
24 months
Personal weight loss goal
Time Frame: 3 months
Reaching percent body weight loss goal (7% of body weight) from baseline to 3 months after the beginning of the intervention. Weight in kg.
3 months
Personal weight loss goal
Time Frame: 12 months
Reaching percent body weight loss goal (7% of body weight) 12 months after the beginning of the intervention. Weight in kg.
12 months
Personal weight loss goal
Time Frame: 24 months
Reaching percent body weight loss goal (7% of body weight) 24 months after the beginning of the intervention. Weight in kg.
24 months
Personal exercise goal
Time Frame: 3 months
Reaching exercise goal (150 min/week) from baseline to 3 months after the beginning of the intervention. Sum of minutes over 7 days.
3 months
Personal exercise goal
Time Frame: 12 months
Reaching exercise goal (150 min/week) 12 months after the beginning of the intervention. Sum of minutes over 7 days.
12 months
Personal exercise goal
Time Frame: 24 months
Reaching exercise goal (150 min/week) 24 months after the beginning of the intervention. Sum of minutes over 7 days.
24 months
Waist circumference
Time Frame: 3 months
Risk factor for chronic health problems.
3 months
Waist circumference
Time Frame: 12 months
Risk factor for chronic health problems.
12 months
Waist circumference
Time Frame: 24 months
Risk factor for chronic health problems.
24 months
Hemoglobin A1c levels
Time Frame: 3 months
Risk factor for chronic health problems.
3 months
Hemoglobin A1c levels
Time Frame: 12 months
Risk factor for chronic health problems.
12 months
Hemoglobin A1c levels
Time Frame: 24 months
Risk factor for chronic health problems.
24 months
Blood pressure
Time Frame: 3 months
Risk factor for chronic health problems.
3 months
Blood pressure
Time Frame: 12 months
Risk factor for chronic health problems.
12 months
Blood pressure
Time Frame: 24 months
Risk factor for chronic health problems.
24 months
Total cholesterol/HDL ratio
Time Frame: 3 months
Risk factor for chronic health problems.
3 months
Total cholesterol/HDL ratio
Time Frame: 12 months
Risk factor for chronic health problems.
12 months
Total cholesterol/HDL ratio
Time Frame: 24 months
Risk factor for chronic health problems.
24 months
Physical activity duration
Time Frame: 3 months
Total minutes per week.
3 months
Physical activity duration
Time Frame: 12 months
Total minutes per week.
12 months
Physical activity duration
Time Frame: 24 months
Total minutes per week.
24 months
Number of steps taken per week
Time Frame: 3 months
Steps taken per week, recorded using a pedometer.
3 months
Number of steps taken per week
Time Frame: 12 months
Steps taken per week, recorded using a pedometer.
12 months
Number of steps taken per week
Time Frame: 24 months
Steps taken per week, recorded using a pedometer.
24 months
Exercise stress test (EST)
Time Frame: 3 months
3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Report Index of Habit Strength
Time Frame: 3 months
Self-monitoring and behaviors
3 months
Self-Report Index of Habit Strength
Time Frame: 12 months
Self-monitoring and behaviors
12 months
Self-Report Index of Habit Strength
Time Frame: 24 months
Self-monitoring and behaviors
24 months
Habit formation indices of weight tracking
Time Frame: 3 months
Frequency of weight tracking.
3 months
Habit formation indices of weight tracking
Time Frame: 12 months
Frequency of weight tracking.
12 months
Habit formation indices of weight tracking
Time Frame: 24 months
Frequency of weight tracking.
24 months
Habit formation indices of physical activity tracking
Time Frame: 3 months
Frequency of physical activity tracking.
3 months
Habit formation indices of physical activity tracking
Time Frame: 12 months
Frequency of physical activity tracking.
12 months
Habit formation indices of physical activity tracking
Time Frame: 24 months
Frequency of physical activity tracking.
24 months
Habit formation indices of fat grams and calorie tracking
Time Frame: 3 months
Frequency of food tracking.
3 months
Habit formation indices of fat grams and calorie tracking
Time Frame: 12 months
Frequency of food tracking.
12 months
Habit formation indices of fat grams and calorie tracking
Time Frame: 24 months
Frequency of food tracking.
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ilka Lowensteyn, PhD, McGill University
  • Study Director: Lawrence Joseph, PhD, McGill University
  • Study Director: Aleksandra Luszczynska, PhD, University of Colorado, Denver
  • Study Director: Steven Grover, MD, McGill University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2013

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

December 6, 2013

First Submitted That Met QC Criteria

December 6, 2013

First Posted (Estimate)

December 11, 2013

Study Record Updates

Last Update Posted (Actual)

March 21, 2018

Last Update Submitted That Met QC Criteria

March 20, 2018

Last Verified

March 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Enriched GLB

Subscribe